- Country: Canada
- Summary: Feasibility Study for Utilities and Ventilation Risk - Clinical Trial Material Facility
- CAT Ref No: 111063906
- Deadline: 23 Dec 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 24-58190
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Feasibility Study for Utilities and Ventilation Risk Mitigation Services for a new Clinical Trial Manufacturing Facility . The National Research Council of Canada is building a new Clinical Trial Manufacturing Facility (CTMF) that will house the process and equipment for the production and the quality control of protein, viral vector or virus-like particle vaccines or biologics. The products are mainly intended for the Canadian market, regulated by Health Canada under the authority of the Food and Drugs Act. The facility will require being compliant with Canadian Good Manufacturing Practices (GMP) as well as FDA current GMP (cGMP) and Eudralex requirements. The new manufacturing rooms and airlocks (personnel and material) will be built in an extension to the existing NRC-s premises located in Montreal, Quebec and will consist of classified grade C and D areas. The facility will include equipment and infrastructures necessary for viral seed stock preparation, subculture, cell culture and viral production, purification and warehousing. The facility was designed to operate under normal environmental condition and Hydro-Quebec power supply. As CTMF is ramping towards onboarding a client and initiate GMP production runs, several challenges have emerged impacting our utilities and ventilation.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINFeasibility Study for Utilities and Ventilation Risk - Clinical Trial Material Facility - Canada Tender
The NATIONAL RESEARCH COUNCIL CANADA, a Government sector organization in Canada, has announced a new tender for Feasibility Study for Utilities and Ventilation Risk - Clinical Trial Material Facility. This tender is published on CanadaTenders under CAT Ref No: 111063906 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-12-23.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
